"This new formulation underscores our commitment to improving the lives of patients by offering another treatment option for patients," said Tim Cogin, fertility and biosimilars director at Organon Australia and New Zealand.
Organon welcomes PBS listing of new citrate-free adalimumab biosimilar
October 1, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
New Zealand to streamline access to ADHD treatments
June 26, 2025 - - Latest News -
CLEO strengthens FDA submission following Access to globally recognised Biobank
June 25, 2025 - - Australian Biotech -
Leukaemia Foundation calls for urgent action to address diagnosis and treatment gaps
June 25, 2025 - - Latest News -
QBiotics' candidate produces strong efficacy result in soft tissue sarcoma trial
June 25, 2025 - - Latest News -
Noxopharm says clinical trial recruitment progressing rapidly
June 25, 2025 - - Australian Biotech -
AusBiotech leads global engagement to strengthen Australia's life sciences sector
June 25, 2025 - - Australian Biotech -
NT doctors want action as whooping cough cases soar
June 25, 2025 - - Latest News